Related Experiment Video
Updated: Mar 26, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
ksRepo: a generalized platform for computational drug repositioning
Adam S Brown1, Sek Won Kong2, Isaac S Kohane3
1Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA. adambrown@fas.harvard.edu.
This study introduces ksRepo, a generalized computational drug repositioning tool that integrates diverse gene expression data and chemical databases. ksRepo successfully identified known prostate cancer therapies, demonstrating its effectiveness in novel drug discovery.
Area of Science:
- Computational biology
- Pharmacology
- Bioinformatics
Background:
- Drug repositioning is crucial for the pharmaceutical industry, but current computational methods often require specific data inputs, limiting their applicability.
- There's a need for generalized methodologies that can integrate various gene expression data types and database schemas for drug repositioning.
Purpose of the Study:
- To develop a generalized computational methodology for drug repositioning that accommodates diverse data inputs.
- To present ksRepo, a novel tool designed to overcome the limitations of existing drug repositioning techniques.
Main Methods:
- ksRepo was developed as a series of four functions in the R statistical environment.
- The tool was tested using five prostate cancer datasets and the Comparative Toxicogenomics Database (CTD) for gene-compound interactions.
Main Results:
- ksRepo successfully identified five frontline prostate cancer therapies from over 7000 compounds in the CTD.
- The method demonstrated significant enrichment in predictions and achieved specificity comparable to existing repositioning approaches.
- ksRepo eliminates the need for a single microarray platform and supports various drug and chemical exposure databases.
Conclusions:
- ksRepo provides a flexible and generalized approach to computational drug repositioning, enabling the use of any data inputs.
- The source code and a user guide (vignette) are freely available, facilitating broader adoption and application of the tool.
More Related Videos
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
05:50Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Pharmacogenomics: Identification of New Drug Targets
Prodrugs
Prodrugs help overcome...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Quantitative Aspects of Drug-Receptor Interaction